e-learning
resources
Monograph
2016
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Biomarkers
Maria A. Kokosi, Elisabetta Renzoni, Francesco Bonella
Source:
Eur Respir Monogr 2016; 71: 122-142
Journal Issue:
Idiopathic Pulmonary Fibrosis
Disease area:
Interstitial lung diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Maria A. Kokosi, Elisabetta Renzoni, Francesco Bonella. Biomarkers. Eur Respir Monogr 2016; 71: 122-142
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Serum KL-6 as a biomarker for interstitial lung diseases in a clinical setting: application of a fully automated immunoassay.
The cryoTBB role in the diagnostic work-up of IPF: an European perspective; emergent standardization guidelines
Acute exacerbations of IPF: A neglected threat in IPF ?
Related content which might interest you:
Comprehensive Metabolic Profiling Reveals Metabolic Perturbances and Identifies Potential Biomarkers in Chronic Persistent Bronchial Asthma with Different Levels of Eosinophilia Percentage
Source: International Congress 2019 – Evaluation of basic science in airway diseases
Year: 2019
Evaluation of New Biomarkers in Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure
Source: International Congress 2017 – Pleural and mediastinal malignancies
Year: 2017
Biomarkers for clinical management
Source: International Congress 2017 – PG12 Life-threatening pulmonary infections
Year: 2017
Endothelial dysfunction in High Altitude Pulmonary Edema: Risk factors and Biomarkers
Source: ERS Research Seminar 2016 - Pulmonary Vascular Endothelium: Orchestra Conductor in Respiratory Diseases - Highlights from Basic Research to Therapy
Year: 2016
Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Biomarkers and personalised treatment
Source: Annual Congress 2012 - MS6 Severe asthma: diagnosis and treatment
Year: 2012
Main and additional predictors of COPD progression
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Molecular Markers of Telomere Dysfunction and Senescence are Common Findings in the Usual Interstitial Pneumonia Pattern of Lung Fibrosis
Source: International Congress 2018 – Progress in basic and translational research on idiopathic interstitial pneumonias
Year: 2018
Inflammatory Pathways and Mediators in the Pathogenesis of Severe Asthma
Source: Research Seminar 2007 - Severe Asthma
Year: 2007
Exposure/Effect Biomarkers and Respiratory Adverse Outcomes in Metal Plating Workers
Source: International Congress 2018 – Occupational and environmental lung diseases: mechanisms, biomarkers and causation
Year: 2018
The Dietary Fiber Intake and its Relationship of Lung Function and Inflammatory Markers in Korean Adults
Source: International Congress 2019 – Epidemiology of airway diseases in primary care
Year: 2019
Characterization of the Immune Response in Clinical Sepsis To Identify Potential Therapeutic Targets
Source: Virtual Congress 2020 – Biomarkers and characterisation of immune response in respiratory infection
Year: 2020
Assessment of inflammatory biomarkers and oxidative stress in pulmonary thromboembolism
Source: Annual Congress 2013 –Pulmonary circulation: acute pulmonary tromboembolism
Year: 2013
1-?-alkyl-glycerols Reduce Level of Inflammatory Cytokines In Obese Asthma
Source: Virtual Congress 2021 – Pharmacology of airway diseases: clinical and laboratory studies
Year: 2021
Biomarkers of oxidative-stress and inflammation in exhaled breath of hospital cleaners
Source: International Congress 2015 – Occupational and environmental exposure assessment and biomarkers
Year: 2015
Prognostic Significance of Hematologic Biomarkers in Small Cell Lung Cancer: a Meta Analysis and Systematic Review
Source: International Congress 2019 – Biology of lung cancer
Year: 2019
IL-21: A Potential Biomarker For Diagnosis and Predicting Prognosis in COVID-19 Patients
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021
Metabolic biomarker validation and clinomics of World Trade Center-Lung injury
Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes
Year: 2016
Feasibility of measuring sputum rheology in COPD
Source: International Congress 2014 – Mechanisms of COPD and inhalation injury
Year: 2014
Managing T2-High Inflammation in Severe Asthma - Are Biomarkers Better Than Clinician Judgement?
Source: Virtual Congress 2020 – Asthma and cough: clinical trials and pharmacological insights
Year: 2020
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept